Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel

Impact of CaMKK2 inhibition in tumor-associated myeloid cells on CD8+cytotoxic T-cell recruitment into mammary tumors.

Publication ,  Conference
Mukherjee, D; Baldi, R; Chang, C-Y; Racioppi, L; McDonnell, DP
Published in: Cancer Immunology Research
March 1, 2020

Duke Scholars

Published In

Cancer Immunology Research

EISSN

2326-6074

ISSN

2326-6066

Publication Date

March 1, 2020

Volume

8

Issue

3

Start / End Page

56 / 57

Publisher

AMER ASSOC CANCER RESEARCH

Related Subject Headings

  • 1115 Pharmacology and Pharmaceutical Sciences
  • 1112 Oncology and Carcinogenesis
  • 1107 Immunology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Mukherjee, D., Baldi, R., Chang, C.-Y., Racioppi, L., & McDonnell, D. P. (2020). Impact of CaMKK2 inhibition in tumor-associated myeloid cells on CD8+cytotoxic T-cell recruitment into mammary tumors. In Cancer Immunology Research (Vol. 8, pp. 56–57). AMER ASSOC CANCER RESEARCH.
Mukherjee, Debarati, Robert Baldi, Ching-Yi Chang, Luigi Racioppi, and Donald P. McDonnell. “Impact of CaMKK2 inhibition in tumor-associated myeloid cells on CD8+cytotoxic T-cell recruitment into mammary tumors.” In Cancer Immunology Research, 8:56–57. AMER ASSOC CANCER RESEARCH, 2020.
Mukherjee D, Baldi R, Chang C-Y, Racioppi L, McDonnell DP. Impact of CaMKK2 inhibition in tumor-associated myeloid cells on CD8+cytotoxic T-cell recruitment into mammary tumors. In: Cancer Immunology Research. AMER ASSOC CANCER RESEARCH; 2020. p. 56–7.
Mukherjee, Debarati, et al. “Impact of CaMKK2 inhibition in tumor-associated myeloid cells on CD8+cytotoxic T-cell recruitment into mammary tumors.Cancer Immunology Research, vol. 8, no. 3, AMER ASSOC CANCER RESEARCH, 2020, pp. 56–57.
Mukherjee D, Baldi R, Chang C-Y, Racioppi L, McDonnell DP. Impact of CaMKK2 inhibition in tumor-associated myeloid cells on CD8+cytotoxic T-cell recruitment into mammary tumors. Cancer Immunology Research. AMER ASSOC CANCER RESEARCH; 2020. p. 56–57.

Published In

Cancer Immunology Research

EISSN

2326-6074

ISSN

2326-6066

Publication Date

March 1, 2020

Volume

8

Issue

3

Start / End Page

56 / 57

Publisher

AMER ASSOC CANCER RESEARCH

Related Subject Headings

  • 1115 Pharmacology and Pharmaceutical Sciences
  • 1112 Oncology and Carcinogenesis
  • 1107 Immunology